News · 26 weeks63+220%
2026-03-012026-08-23
Mix2390d
- SEC Filings8(35%)
- Insider8(35%)
- Other5(22%)
- Earnings2(9%)
Latest news
25 items- INSIDERChief Marketing Officer Gee David Nicholas sold $49,111 worth of Ordinary shares (4,323 units at $11.36) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 135,281 units (SEC Form 4)4 - Cellebrite DI Ltd. (0001854587) (Issuer)
- SECSEC Form 144 filed by Cellebrite DI Ltd.144 - Cellebrite DI Ltd. (0001854587) (Subject)
- INSIDERGlobal Chief Revenue Officer Jewell Marcus sold $141,217 worth of Ordinary shares (12,562 units at $11.24), decreasing direct ownership by 3% to 427,128 units (SEC Form 4) (for tax liability)4 - Cellebrite DI Ltd. (0001854587) (Issuer)
- INSIDERChief Marketing Officer Gee David Nicholas sold $24,709 worth of Ordinary shares (2,198 units at $11.24), decreasing direct ownership by 2% to 139,604 units (SEC Form 4) to satisfy withholding tax4 - Cellebrite DI Ltd. (0001854587) (Issuer)
- PRCellebrite Genesis for Enterprise Now Generally Available, Regional Availability Expands to More Global MarketsTYSONS CORNER, Va. and PETAH TIKVA, Israel, Aug. 19, 2026 /CNW/ -- Cellebrite DI Ltd. (NASDAQ:CLBT), a global leader in AI-powered Digital Investigative and Intelligence solutions for the public and private sectors, today announced that Cellebrite Genesis is expanding to more global markets and is now generally available for enterprise organizations. The expansion builds on a successful early access program and strong momentum following Genesis' June 2026 public safety launch. Genesis has seen meaningful user growth worldwide and continues to expand internationally, with availability now in Australia and the United Kingdom and is expected to be available to the European Union later this mont
- SECSEC Form 144 filed by Cellebrite DI Ltd.144 - Cellebrite DI Ltd. (0001854587) (Subject)
- SECSEC Form SCHEDULE 13G filed by Cellebrite DI Ltd.SCHEDULE 13G - Cellebrite DI Ltd. (0001854587) (Subject)
- SECSEC Form 6-K filed by Cellebrite DI Ltd.6-K - Cellebrite DI Ltd. (0001854587) (Filer)
- INSIDERChief Executive Officer Hogan Thomas E. was granted 339,484 units of Ordinary shares and sold $2,149,638 worth of Ordinary shares (139,713 units at $15.39), increasing direct ownership by 34% to 790,548 units (SEC Form 4) (tax withholding)4 - Cellebrite DI Ltd. (0001854587) (Issuer)
- SECSEC Form 6-K filed by Cellebrite DI Ltd.6-K - Cellebrite DI Ltd. (0001854587) (Filer)
- SECSEC Form 6-K filed by Cellebrite DI Ltd.6-K - Cellebrite DI Ltd. (0001854587) (Filer)
- INSIDERGlobal Chief Revenue Officer Jewell Marcus sold $6,604 worth of Ordinary shares (411 units at $16.07), decreasing direct ownership by 0.09% to 439,690 units (SEC Form 4) (withholding tax)4 - Cellebrite DI Ltd. (0001854587) (Issuer)
- INSIDERChief Marketing Officer Gee David Nicholas sold $3,696 worth of Ordinary shares (230 units at $16.07), decreasing direct ownership by 0.16% to 141,802 units (SEC Form 4) to cover taxes4 - Cellebrite DI Ltd. (0001854587) (Issuer)
- SECSEC Form 6-K filed by Cellebrite DI Ltd.6-K - Cellebrite DI Ltd. (0001854587) (Filer)
- PRCellebrite Appoints Shiven Ramji Chief Executive Officer, Succeeding Thomas E. HoganCompany Reports Second-Quarter 2026 Results; Company Lowers Full-Year 2026 ARR and Revenue Outlook and Raises Adjusted EBITDA TargetTYSONS CORNER, Va. and PETAH TIKVA, Israel, Aug. 13, 2026 /PRNewswire/ -- Cellebrite DI Ltd. (NASDAQ:CLBT), a global leader in AI-powered Digital Investigative and Intelligence solutions for the public and private sectors, today announced that Shiven Ramji, who joined Cellebrite as President, Products and Technology in May 2026, has succeeded Thomas E. Hogan as the Company's CEO as part of a planned transition, effective immediately. In addition, Ramji will be appointed to the Company's Board of Directors. Hogan joined Cellebrite as Executive Chairman in August
- SECSEC Form 144 filed by Cellebrite DI Ltd.144 - Cellebrite DI Ltd. (0001854587) (Subject)
- PRCellebrite to Report Second-Quarter 2026 Financial Results on August 13, 2026TYSONS CORNER, Va. and PETAH TIKVA, Israel, July 21, 2026 /CNW/ -- Cellebrite DI Ltd. (NASDAQ:CLBT), a global leader in AI-powered Digital Investigative and Intelligence solutions for the public and private sectors, today announced it will report its second-quarter 2026 financial results before the U.S. markets open on Thursday, August 13, 2026. Later that same morning, Cellebrite will host a live conference call and webcast to review the Company's financial results for the second quarter of 2026 and discuss its 2026 outlook. Relevant details include:Date:Thursday, August 13, 2026Time:8:30 a.m. ETCall-In Number:785-838-9251 / 8
- INSIDERChief Financial Officer Barter David sold $683,419 worth of Ordinary shares (41,734 units at $16.38), decreasing direct ownership by 11% to 334,219 units (SEC Form 4) to satisfy withholding tax4 - Cellebrite DI Ltd. (0001854587) (Issuer)
- PRCellebrite Expands Exclusive SkySafe Partnership to Deliver Immediate Drone Detection and Airspace Intelligence for Digital Investigations at ScaleThe partnership unifies what happens in the sky with what's stored on the drone in a single investigative workflowTYSONS CORNER, Va. and PETAH TIKVA, Israel, July 8, 2026 /CNW/ -- Cellebrite DI Ltd. (NASDAQ:CLBT), a global leader in AI-powered Digital Investigative and Intelligence solutions for the public and private sectors, today announced an expanded partnership with SkySafe, the leader in drone detection and airspace intelligence. The exclusive partnership combines advanced digital forensics with advanced drone detection, deep analysis and drone activity, equipping organizations and agencies with the intelligence needed to proactively detect, analyze and act on potential threats in real
- INSIDERChief Executive Officer Hogan Thomas E. sold $1,625,892 worth of Ordinary shares (103,188 units at $15.76), decreasing direct ownership by 15% to 590,777 units (SEC Form 4) to satisfy tax liability4 - Cellebrite DI Ltd. (0001854587) (Issuer)
- SECSEC Form 144 filed by Cellebrite DI Ltd.144 - Cellebrite DI Ltd. (0001854587) (Subject)
- PRCellebrite Launches the New Age of Investigations with Genesis, Now Generally AvailableReduces investigative workloads from weeks to minutes accelerating investigations like never beforeTYSONS CORNER, Va. and PETAH TIKVA, Israel, June 10, 2026 /CNW/ -- Cellebrite DI Ltd. (NASDAQ:CLBT), a global leader in AI-powered Digital Investigative and Intelligence solutions for the public and private sectors, today announced Cellebrite Genesis general availability. Genesis allows investigators faced with increasing crime and data types to quickly and intuitively interrogate digital evidence using the product's agentic AI capabilities to surface intelligence in minutes rather than days or weeks. The need for AI-powered inves
- PRCellebrite Announces Upcoming Investor Events on June 10, 2026TYSONS CORNER, Va. and PETAH TIKVA, Israel, June 5, 2026 /CNW/ -- Cellebrite DI Ltd. (NASDAQ:CLBT), a global leader in AI-powered Digital Investigative and Intelligence solutions for the public and private sectors, today announced that the Company plans to participate in two upcoming investor events on June 10, 2026. Date:June 10, 2026Event:Cellebrite AI Technology Talk Overview: A deep dive into AI at Cellebrite – from vulnerability research to internal use and the introduction of Genesis, the Company's new agentic AI platform for investigations Presentation Time:9:00 a.m. ETFormat: WebcastEvent URL: https://investors.cellebri
- ANALYSTDA Davidson initiated coverage on Cellebrite DI with a new price targetDA Davidson initiated coverage of Cellebrite DI with a rating of Buy and set a new price target of $20.00
- INSIDERChief Marketing Officer Gee David Nicholas sold $74,477 worth of Ordinary shares (5,673 units at $13.13) as part of a pre-agreed trading plan, decreasing direct ownership by 4% to 142,032 units (SEC Form 4) (withholding tax)4 - Cellebrite DI Ltd. (0001854587) (Issuer)
CLBT FAQ
6 questionsWhat does Cellebrite DI Ltd. do?
Cellebrite DI Ltd. provides digital intelligence solutions for the public and private sectors worldwide. The company offers Cellebrite UFED, a platform for lawfully accessing and collecting digital data; Cellebrite physical analyzer, a digital data examiner; Cellebrite UFED Cloud, a platform that allow to collect, preserve, and analyze public and private-domain, social-media data, instant messaging, file storage, web pages, and other cloud-based content; Cellebrite Frontliner that collects digital evidence in real-time; Cellebrite Responder; and Cellebrite Premium. It also provides Cellebrite...Where does CLBT stock trade?
Cellebrite DI Ltd. (CLBT) is listed on NASDAQ.What sector and industry is CLBT in?
Cellebrite DI Ltd. operates in the Technology sector, Computer Software: Prepackaged Software industry.What are analysts saying about CLBT?
Cellebrite DI Ltd. has had 8 recent analyst actions on file. The most recent action was from DA Davidson: Buy with a $2000.00 price target on 2026-05-27. Recent price targets range from $600.00 to $2000.00.What companies are similar to CLBT?
Notable peers in the same industry include MSFT (Microsoft Corporation), ORCL (Oracle Corporation), SAP (SAP SE), CRWD (CrowdStrike Holdings Inc.), CRM (Salesforce Inc.). Compare CLBT side-by-side with any of them on Quantisnow.How can I track CLBT on Quantisnow?
Quantisnow aggregates Cellebrite DI Ltd.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow CLBT to receive live email and push alerts on every new disclosure.